BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+0.7%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.31B
AUM Growth
+$1.31B
(-1.2%)
Cap. Flow
+$2.33M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
|
$2.33M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 50.71% |
| 2 | Consumer Staples | 30.9% |
| 3 | Industrials | 6.71% |
| 4 | Technology | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $606M | 46.26% |
8,592,007
| – | – |
|
2
Monster Beverage
MNST
$60.9B
| $405M | 30.9% |
4,656,488
| – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $114M | 8.69% |
690,000
| – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $88M | 6.71% |
760,062
| – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $39.5M | 3.01% |
34,935,485
| – | – |
|
|
BTRS
6
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $39.2M | 2.99% |
4,229,652
+251,951
| +6% | +$2.33M |
|
|
IMDX
7
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $17M | 1.3% |
23,353,697
| – | – |
|
8
Serina Therapeutics
SER
$54.5M
| $1.68M | 0.13% |
2,997,156
| – | – |
|